We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App





Sugar-Coated COVID-19 Test Strip Detects All Known Coronavirus Variants

By LabMedica International staff writers
Posted on 16 Dec 2021

Researchers have taken advantage of the coronavirus’ sweet tooth by designing a sugar-coated COVID-19 test strip that has proved effective at detecting all known variants of the virus, including delta. More...

In the next few weeks, researchers at the University of North Carolina at Chapel Hill (Chapel Hill, NC, USA) and University of California San Diego (La Jolla, CA, USA) will determine if the self-test known as GlycoGrip can detect infections caused by the omicron variant as well. The test is inspired by the natural biology of epithelial cells – those that are targeted and infiltrated by SARS-CoV-2, the virus that causes COVID-19. These cells are coated with a dense matrix of sugars called the glycocalyx, and it’s this sugar net that the virus exploits to cause infection.

The concept is intuitive: a droplet of biofluid containing the virus, such as saliva, is placed on one end of the strip and flows along the surface. When the fluid reaches a sugar-coated patch, the virus can’t help but indulge its sweet tooth, becoming trapped on that specific area. This capture is then signaled by antibodies treated with gold nanoparticles producing a visual color that indicates infection.

To better understand how these sugar polymers bind the virus, the team developed computationally intensive simulations that helped explain the mechanics behind how and why the cell-anchored sugars bind the viral spikes. One of the greatest challenges of the ongoing COVID-19 pandemic has been responding to the virus’ mutations and emerging variants. New tests must be developed for new tweaks in the virus’ genetic code. But GlycoGrip offers a solution for universal coronavirus testing.

“We have turned the tables on the virus by using the same sugar coat it binds to infect cells – to capture it into our sensor,” said Carolina researcher Ronit Freeman. “We tapped into nature to reimagine viral diagnostics. We are optimistic that GlycoGrip will capture future variants just as easily.”

“By using atomic-level views of the spike protein, we were able to identify key binding sites for the glycocalyx sugar polymers and unlock how these sugars adapt to different spike conformations,” said Rommie Amaro, professor of chemistry and biochemistry at the University of California San Diego. “This is exciting, we essentially revealed another secret of how spike binds cells to facilitate infection.”

Related Links:
University of North Carolina at Chapel Hill 
University of California San Diego 


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Celiac Disease Test
Anti-Gliadin IgG ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.